Ever since her son, Drew, was diagnosed with Phelan-Mcdermid Syndrome (PMS), Denmark has fought tirelessly to raise awareness about the rare genetic condition caused by the deletion of chromosome ...

“By focusing on the genetic underpinnings of Phelan-McDermid Syndrome—a syndromic form of autism—we aim to address the root cause of symptoms and offer new hope where few options currently ...

The FDA has granted Orphan Drug Designation to NeuroNOS's BA-102 for treating Phelan-McDermid Syndrome, initiating trials in 2026. NeuroNOS, a subsidiary of Beyond Air, has received Orphan Drug ...

A first-in-human clinical trial is expected to being in the US in 2026. The Food and Drug Administration (FDA) has granted Orphan Drug designation to BA-102 for the treatment of Phelan-McDermid ...

A non-interventional study published in Frontiers in Psychiatry Psychometric profile characterization of 30 subjects with Phelan-McDermid Syndrome (PMS), defining three distinct subsets Study provides ...

"Amelia was diagnosed with ring chromosome 22 at the age of 2, and then she has a syndrome called Phelan-McDermid syndrome," mother Kristin Hannon said. "She needs help and caregiving 24/7." ...